Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Medtronic
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Covington
Deloitte
Accenture
Citi
Julphar

Generated: August 22, 2017

DrugPatentWatch Database Preview

Oxycodone - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxycodone and what is the scope of oxycodone freedom to operate?

Oxycodone
is the generic ingredient in six branded drugs marketed by Collegium Pharm Inc, Novel Labs Inc, Mayne Pharma Inc, West-ward Pharms Int, Wes Pharma Inc, Mallinckrodt Inc, Vintage Pharms, Alvogen Malta, Ken Lifescience, Lannett Holdings Inc, Roxane, Lehigh Valley, Actavis Elizabeth, Vistapharm, Amneal Pharms, Wockhardt Bio Ag, Sun Pharm Inds Inc, Aurolife Pharma Llc, Epic Pharma Llc, Purdue Pharma Lp, Avanthi Inc, Ani Pharms Inc, Inspirion Delivery, Egalet Us Inc, Nesher Pharms, and Rhodes Pharms, and is included in thirty-eight NDAs. There are thirty-three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Oxycodone has fourteen patent family members in five countries.

There are seventeen drug master file entries for oxycodone. One supplier is listed for this compound. There are four tentative approvals for this compound.

Summary for Generic Name: oxycodone

Tradenames:6
Patents:33
Applicants:26
NDAs:38
Drug Master File Entries: see list17
Suppliers / Packagers: see list1
Bulk Api Vendors: see list14
Clinical Trials: see list343
Patent Applications: see list14,379
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxycodone at DailyMed

Pharmacology for Ingredient: oxycodone

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Tentative approvals for OXYCODONE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe80MGTABLET, EXTENDED RELEASE; ORAL
► Subscribe► Subscribe80MGTABLET, EXTENDED RELEASE; ORAL
► Subscribe► Subscribe40MGTABLET, EXTENDED RELEASE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-004Apr 5, 2010RXYesNo► Subscribe► Subscribe ► Subscribe
Novel Labs Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL204021-001Jun 12, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Ken Lifescience
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL207119-003Apr 12, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-004Apr 5, 2010RXYesNo► Subscribe► SubscribeY ► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-002Apr 5, 2010RXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: oxycodone

Country Document Number Estimated Expiration
Japan2017101075► Subscribe
European Patent Office1765292► Subscribe
Japan4694207► Subscribe
Canada2569958► Subscribe
Australia2003247876► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: OXYCODONE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292Luxembourg► SubscribePRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Chinese Patent Office
Mallinckrodt
Deloitte
QuintilesIMS
Fuji
Novartis
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot